Clinical Trial Update: Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating whether epigallocatechin gallate (EGCG) influences Epstein-Barr virus reactivation in patients in remission from nasophary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Epigallocatechin Gallate (EGCG) (epigallocatechin gallate)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: NPC | NA | Status: COMPLETED